Physician profile
Daniel Bruce Eddelman
NPI 1861807844
$48,960.71
in general payments reported to CMS, 2019-2025
10 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $223 · 2021: $22K · 2022: $25K · 2023: $18.80 · 2024: $28.61 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $44,996.00 | 2021-2022 | |
| Stryker Corporation | $2,910.14 | 2019-2023 | Spinejack |
| Medtronic, INC. | $274.69 | 2021-2025 | Unid_pass |
| Medtronic USA, INC. | $174.71 | 2019-2020 | |
| Icotec Medical INC. | $163.50 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Depuy Synthes Sales INC. | $121.23 | 2020 | |
| Zimmer Biomet Holdings, INC. | $106.72 | 2019 | |
| Seaspine Orthopedics Corporation | $100.84 | 2019 | |
| Djo, LLC | $56.69 | 2024-2025 | Cmf |
| Integra Lifesciences Corporation | $56.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Eddelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.